1 / 12

Glaucoma Market

DelveInsightu2019s u2018Glaucomau2014Market Insights, Epidemiology, and Market Forecastu20132030u2019 report deliver an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. <br><br>

yashb
Télécharger la présentation

Glaucoma Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Glaucoma Presented by- DelveInsight Business Research

  2. What is Glaucoma Market? DelveInsight’s Glaucoma Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the Glaucoma, historical and forecasted epidemiology as well as the Glaucoma market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

  3. The Glaucoma market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Glaucoma market size from 2018 to 2030. The Report also covers current Glaucoma treatment practice, market drivers, market barriers, SWOT analysis, reimbursement, and market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

  4. Open-angle glaucoma (OAG) is the most common form of the disease. The drainage angle formed by the cornea and iris remains open, but the trabecular meshwork is partially blocked. This causes pressure in the eye to increase gradually and damages the optic nerve. It happens so slowly that the patient may lose vision before they are even aware of a problem, while in the case of narrow-angle glaucoma, the structure inside the eye that allows fluid to drain normally from the eye (called the drainage angle) becomes restricted. Narrow drainage angles in the eye increase the risk of the drainage angle that gets blocked, resulting in a significant increase in eye pressure and risk of vision loss. If this occurs, narrow-angle glaucoma is usually called angle-closure glaucoma.

  5. How Many Regions Are Covered? The US EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan

  6. What are the major types of Glaucoma? There are two major types of glaucoma, i.e., Primary open-angle glaucoma (POAG), and Angle-closure /glaucoma closed-angle glaucoma/narrow-angle glaucoma. The “angle” in both cases refers to the drainage angle inside the eye that controls the outflow of the watery fluid (aqueous) which is being produced inside the eye.

  7. Glaucoma Emerging Drugs PDP-716: Sun Pharma Advanced Research Company Limited (SPARC) PRO-122: Laboratorios Sophia S.A de C.V.

  8. What is the Glaucoma Market Report Scope? • The report covers the descriptive overview of Glaucoma, explaining its causes, symptoms, pathophysiology, genetic basis, and currently available therapies. • Comprehensive insight has been provided into the Glaucoma epidemiology and treatment. • Additionally, an all-inclusive account of both the current and emerging therapies for Glaucoma is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape. • A detailed review of the Glaucoma market; historical and forecasted is included in the report, covering the 7MM drug outreach. • The report provides an edge while developing business strategies, by understanding trends shaping and driving the 7MM Glaucoma market

  9. What are the Glaucoma MarketReport Highlights? • The robust pipeline with novel MOA and oral ROA, increasing prevalence, effectiveness of drugs as both mono and combination therapy will positively drive the Glaucoma market. • The companies and academics are working to assess challenges and seek opportunities that could influence Glaucoma R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition. • Major players are involved in developing therapies for Glaucoma. The launch of emerging therapies will significantly impact the Glaucoma market. • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

  10. info@delveinsight.com ybhardwaj@delveinsight.com +91-9650213330 Do You Have Any Question or Query? Please keep this slide for attribution

  11. Thanks!

More Related